timothy sykes logo

Stock News

Why Oscar Health Shares Fell Today

Ellis HobbsAvatar
Written by Ellis Hobbs Reviewed by Jack Kellogg Fact-checked by Tim Sykes
Updated 7/21/2025, 2:33 pm ET 7/21/2025, 2:33 pm ET | 5 min 5 min read
Why Oscar Health Shares Fell Today Thumbnail

Oscar Health Inc.’s stocks have been trading up by 3.18 percent amid optimism over innovative healthcare initiatives.

Candlestick Chart

Live Update At 14:32:41 EST: On Monday, July 21, 2025 Oscar Health Inc. stock [NYSE: OSCR] is trending up by 3.18%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Recent Earnings Overview

Oscar Health, Inc. recently released its quarterly earnings report. The company witnessed a revenue stream reaching $9.177B, a significant achievement, yet the market seemed dissatisfied. The revenue per share stood at around $41.87, yet the fluctuation in stock value reveals a different sentiment among investors.

Despite achieving a commendable gross premium collection of $2,995.82M, operating challenges with total expenses reaching nearly $2.75B strained profitability. Overall, the positive movement in their stock income didn’t sway investor skepticism, leading to stock price slippage.

Financial Metrics & Insights

Looking at Oscar Health’s key financial ratios, several metrics stand out. The EBIT margin remains negative at -0.3, which can raise red flags for those wary of efficiency at an operational level. As millionaire penny stock trader and teacher Tim Sykes, says, “Be patient, don’t force trades, and let the perfect setups come to you.” This approach encourages traders to remain calm and wait for the right opportunities, which seems to resonate well with Oscar Health’s intriguing positive profit margin contribution at 1.66, indicating a profitable element within complex financial structures.

For investors, a Price-to-Book ratio of 2.56 is worth noting, along with a Price-to-Cash Flow ratio of 1. This valuation measure might indicate decent financial footing but must be weighed against risk factors like Return on Equity at -22.75, revealing strategic inefficiencies in equity capital utilization.

More Breaking News

From a financial strength perspective, Oscar Health currently maintains a debt-free stance with a total debt-to-equity ratio of zero, which surprisingly, isn’t enough to bolster overall market sentiment.

Decoding the Market Impact

Raymond James’ downgrade indicates a perceived expected decline in performance, making potential investors cautious. The company’s quarterly results failed to uplift the stock, as high expenses, despite robust earnings, caused apprehension. Historically, downgrades often lead to downward pressure on share prices because they signal potential future woes to current and potential investors.

The subtle indicators of decreased investor trust reflected in the market response. Oscar Health remains an intriguing player to monitor in the healthcare sector, with market enthusiasts waiting for the right cues to bolster confidence in the forthcoming quarters.

Concluding Thoughts

In the recent market landscape, Oscar Health’s shares have experienced a notable decline following the Raymond James downgrade. While the company’s operational strategies and income generation are steadily on course, trader skepticism lingers due to profitability concerns marked by thinning margins and substantial operational expenses.

As the company forges ahead, it must address these critical financial metrics to instill heightened trust among shareholders. Understanding Oscar Health’s comprehensive financial backdrop and news impact is crucial for gauging its future trajectory, which now sits in a delicate balance between performance and perception. As millionaire penny stock trader and teacher Tim Sykes says, “Preparation plus patience leads to big profits.” This serves as a reminder that traders should exhibit diligence and patience as they navigate the complexities of Oscar Health’s current situation.

Looking forward, traders should keep an eye on further developments and market trends to ascertain potential recovery or continued decline. Careful assessment of external and internal influences will remain pivotal in predicting the bullish or bearish movement of Oscar Health’s stock value.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Ellis Hobbs

Trainer and Mentor on Tim Sykes’ Trading Challenge
He teaches webinars on Tim Sykes’ Trading Challenge He treats trading like a business, not a hobby He emphasizes taking small risks — “If you get the process right, money is a forgone conclusion.”
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”